ESR1 and breast cancer: We have previously reported that CDK8/19 inhibitors prevent the induction of resistance-associated anti-apoptotic factors upon treatment with DNA-damaging drugs or ionizing radiation [25] and suppress the emergence of estrogen-independent ER-positive breast cancer cells upon prolonged estrogen deprivation [33].